Sure Touch Clinical Studies
•Download as PPT, PDF•
2 likes•1,050 views
The document describes a medical device called SureTouch that assesses characteristics of breast tissue through tactile sensors. Several clinical trials found that SureTouch can accurately identify breast lesions, differentiate between benign and malignant tumors with high sensitivity and specificity, and reduce variability compared to standard clinical breast exams. The goals of SureTouch are to improve breast cancer screening and reduce unnecessary biopsies.
Report
Share
Report
Share
![[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Women’s Health Imaging Center Awarded Prestigious Accreditation
Studies on the breast ultrasound technique showed that it is effective at detecting the difference between benign and cancerous tumors, and researchers recommend it as a "tool of choice" for evaluating palpable lumps in women under 40.
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...breastcancerupdatecongress
This document discusses the use of breast MRI in evaluating response to neoadjuvant chemotherapy. MRI can provide both morphological and functional information about tumors. Studies show DCE-MRI and DWI-MRI may help assess response after 1-2 cycles of chemotherapy, with changes in tumor size, kinetic parameters and ADC values predicting pathological complete or near-complete response. Larger prospective trials are still needed to standardize MRI methods and thresholds to determine if changes on MRI could guide modifications to chemotherapy regimens for non-responders. Overall, MRI shows potential as a predictive marker and non-invasive method for monitoring early response to neoadjuvant breast cancer treatment.Liliane ollivier : Breast MR Imaging in Women with High Genetic Risk
1) Breast MRI is useful for screening and surveillance in women with high genetic risk of breast cancer, such as those with BRCA1/BRCA2 mutations. MRI can identify cancers earlier than mammography due to certain features of hereditary breast cancers.
2) For lesions found on MRI, further workup with targeted ultrasound and biopsy is recommended. If no lesion is found on ultrasound, short-term MRI follow up or MRI-guided biopsy may be needed given the increased risk in this patient population.
3) Annual breast MRI, ultrasound and mammography (when applicable) is important for surveillance in high risk women due to the possibility of interval cancers developing between screenings. Following standardized imaging protocols and recommendations
Shared Decision Making, Decision Support and Breast Conservation Therapy
Shared Decision Making, Decision Support and Breast Conservation Therapy explores how breast cancer patients interpret decisions around making decisions about mastectomy vs. lumpectomy.
Breast Density Notification Law Information For Primary Care Providers
Breast Density Notification Law Information For Primary Care ProvidersDepartment of Learning Health Sciences, University of Michigan Medical School
Caren Stalburg, MD, MA presented to the 2016 annual Snow meeting of the Michigan Section of the American Congress of Obstetricians and Gynecologists (ACOG) about her program to train Michigan providers about the new Breast Density Notification Law (http://www.midensebreasts.org/).
Dr. Stalburg is Division Chief and Clinical Assistant Professor in the Division of Professional Education in the Department of Learning Health Sciences and Assistant Professor of Obstetrics and Gynecology in the University of Michigan Medical School. Mri breast (2)
MRI breast imaging is used for screening, diagnosis, and evaluation of breast lesions. It has several indications including screening high risk patients, assessing multicentricity, evaluating postoperative or post-NACT lesions, and assessing Paget's disease. The technique involves sequences like T1, T2, DCE, and DWI. Lesions are characterized by morphological features, kinetic enhancement patterns, and additional findings. MRI is also useful for evaluating breast implants and capsular contracture. Potential pitfalls include pseudoenhancement and normal tissue enhancement.
Comparison between mammogram and mri in detecting breast cancer
MRI mammography is more accurate than mammography in detecting breast diseases. A study compared MRI and mammography on 15 patients and found MRI detected 12 cases of ductal carcinoma in situ (DCIS) in the right breast that mammography missed, as well as 10 cases of DCIS in the left breast. MRI mammography had a sensitivity of 100% while mammography's sensitivity was only 18% for detecting breast cancer. MRI is better able to detect cancers obscured by dense breast tissue and can provide additional information on tumor extent.
Mr Mammography New
MRI can detect breast lesions with high sensitivity but has variable specificity in differentiating benign from malignant lesions. MR spectroscopy provides additional metabolic information that can improve specificity by detecting elevated choline levels associated with malignant tumors. Response to chemotherapy can also be assessed non-invasively with MR spectroscopy by monitoring changes in choline levels within 24 hours of treatment. Limitations include difficulty with small lesions, dense breasts, and lactating breasts.
Recommended
Women’s Health Imaging Center Awarded Prestigious Accreditation
Studies on the breast ultrasound technique showed that it is effective at detecting the difference between benign and cancerous tumors, and researchers recommend it as a "tool of choice" for evaluating palpable lumps in women under 40.
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...breastcancerupdatecongress
This document discusses the use of breast MRI in evaluating response to neoadjuvant chemotherapy. MRI can provide both morphological and functional information about tumors. Studies show DCE-MRI and DWI-MRI may help assess response after 1-2 cycles of chemotherapy, with changes in tumor size, kinetic parameters and ADC values predicting pathological complete or near-complete response. Larger prospective trials are still needed to standardize MRI methods and thresholds to determine if changes on MRI could guide modifications to chemotherapy regimens for non-responders. Overall, MRI shows potential as a predictive marker and non-invasive method for monitoring early response to neoadjuvant breast cancer treatment.Liliane ollivier : Breast MR Imaging in Women with High Genetic Risk
1) Breast MRI is useful for screening and surveillance in women with high genetic risk of breast cancer, such as those with BRCA1/BRCA2 mutations. MRI can identify cancers earlier than mammography due to certain features of hereditary breast cancers.
2) For lesions found on MRI, further workup with targeted ultrasound and biopsy is recommended. If no lesion is found on ultrasound, short-term MRI follow up or MRI-guided biopsy may be needed given the increased risk in this patient population.
3) Annual breast MRI, ultrasound and mammography (when applicable) is important for surveillance in high risk women due to the possibility of interval cancers developing between screenings. Following standardized imaging protocols and recommendations
Shared Decision Making, Decision Support and Breast Conservation Therapy
Shared Decision Making, Decision Support and Breast Conservation Therapy explores how breast cancer patients interpret decisions around making decisions about mastectomy vs. lumpectomy.
Breast Density Notification Law Information For Primary Care Providers
Breast Density Notification Law Information For Primary Care ProvidersDepartment of Learning Health Sciences, University of Michigan Medical School
Caren Stalburg, MD, MA presented to the 2016 annual Snow meeting of the Michigan Section of the American Congress of Obstetricians and Gynecologists (ACOG) about her program to train Michigan providers about the new Breast Density Notification Law (http://www.midensebreasts.org/).
Dr. Stalburg is Division Chief and Clinical Assistant Professor in the Division of Professional Education in the Department of Learning Health Sciences and Assistant Professor of Obstetrics and Gynecology in the University of Michigan Medical School. Mri breast (2)
MRI breast imaging is used for screening, diagnosis, and evaluation of breast lesions. It has several indications including screening high risk patients, assessing multicentricity, evaluating postoperative or post-NACT lesions, and assessing Paget's disease. The technique involves sequences like T1, T2, DCE, and DWI. Lesions are characterized by morphological features, kinetic enhancement patterns, and additional findings. MRI is also useful for evaluating breast implants and capsular contracture. Potential pitfalls include pseudoenhancement and normal tissue enhancement.
Comparison between mammogram and mri in detecting breast cancer
MRI mammography is more accurate than mammography in detecting breast diseases. A study compared MRI and mammography on 15 patients and found MRI detected 12 cases of ductal carcinoma in situ (DCIS) in the right breast that mammography missed, as well as 10 cases of DCIS in the left breast. MRI mammography had a sensitivity of 100% while mammography's sensitivity was only 18% for detecting breast cancer. MRI is better able to detect cancers obscured by dense breast tissue and can provide additional information on tumor extent.
Mr Mammography New
MRI can detect breast lesions with high sensitivity but has variable specificity in differentiating benign from malignant lesions. MR spectroscopy provides additional metabolic information that can improve specificity by detecting elevated choline levels associated with malignant tumors. Response to chemotherapy can also be assessed non-invasively with MR spectroscopy by monitoring changes in choline levels within 24 hours of treatment. Limitations include difficulty with small lesions, dense breasts, and lactating breasts.
Breast imaging pitffals mri p taourel
Breast MRI can have both high sensitivity and specificity for cancer detection but also poses challenges. Specificity may be around 70-90% depending on the population and comparison to mammography. Sensitivity also varies based on the gold standard used, ranging from over 95% in many studies to around 75% for screening studies. Both false positives and false negatives can occur for reasons such as artifacts, normal breast tissue, benign lesions, tumor characteristics like size, and interpretation errors. The document provides guidance on analyzing lesions, potential pitfalls, and ways to improve accuracy such as recognizing pseudo-enhancement, accounting for clinical context, and recommending appropriate follow up.
Riga 2016TomoCESMcombo
- Kettering General Hospital Breast Unit went digital between 2010-2012 and implemented tomosynthesis and contrast-enhanced spectral mammography (CESM) to improve cancer detection for women with dense breasts.
- A review of 50 patients who received tomosynthesis found it aided diagnosis in 36 patients (69%), providing extra information in 22 patients and more detailed information in 7 patients.
- A prospective study of 117 CESM exams found it to be as sensitive as MRI in detecting cancer and impacted management for 30% of cancer patients. CESM provided accurate sizing for invasive cancers but was less accurate for lobular cancers and cancers with ductal carcinoma in situ.
Rx of mammaoccult cancer
Breast Conservation in the Setting of Contemporary
Multimodality Treatment Provides Excellent Outcomes
for Patients with Occult Primary Breast Cancer
Breast Cancer not Detected on MRI
This study evaluated the sensitivity of breast MRI for detecting breast cancers. Of 222 cancers, MRI correctly identified 213 but missed 9 cancers (sensitivity of 96.8%). The 7 true false-negatives included 4 DCIS lesions and 3 invasive cancers. False-negative lesions were often small or obscured by surrounding enhancing breast tissue. While MRI is highly sensitive for breast cancer, a small percentage of cancers can be missed, particularly DCIS and cancers in a background of diffuse parenchymal enhancement.
ABC1 - N. Houssami - Overview of imaging tests for assessment of metastases i...
ABC1 - N. Houssami - Overview of imaging tests for assessment of metastases i...European School of Oncology
The document summarizes evidence from two systematic reviews on imaging tests for detecting bone metastases in breast cancer. The reviews found 16 studies comparing the accuracy of different tests, but the studies were limited by small sample sizes, selection bias, and heterogeneous reference standards of varying quality. While PET or PET/CT appeared more sensitive than bone scans in seven studies, the heterogeneity and risk of misclassification means differences in test accuracy between studies may not represent true differences and prevents pooling of the data. Overall, the evidence was insufficient to support one imaging test over others for detection of bone metastases from breast cancer.ShearWave™ Elastography in Breast Cancer Patient Management: Clinical Researc...
With 100 peer-reviewed publications, SuperSonic Imagine’s proprietary ShearWave™ Elastography (SWE™) is the most clinically studied shear-wave based elastography for breast lesion characterization.
In this all new webinar, we will walk you through a literature review that will help you to familiarize yourself with clinical research results related to the use of ShearWave™ Elastography (SWE™) within breast ultrasound imaging.
Breast screening pallavi
This document provides information on breast cancer screening and prevention. It discusses screening principles and guidelines for mammography, MRI, ultrasound and other screening techniques. It outlines high-risk factors for breast cancer and recommends annual screening starting at age 30-40 for high-risk individuals, including those with BRCA gene mutations or family history. Screening mammography every 1-2 years is recommended for average risk women starting at age 40. Chemoprevention with tamoxifen or raloxifene can lower breast cancer risk in high risk postmenopausal women. Genetic testing guidelines are also provided.
Breast screening with ultrasound in patients with mammography-negative dense ...
The document analyzes the frequency of interval cancers in dense breasts screened with mammography and ultrasound compared to non-dense breasts screened with only mammography. It finds that the frequency of interval cancers in dense breasts screened with both tests is similar to non-dense breasts screened with only mammography. This finding provides convincing evidence that ultrasound improves mammography's sensitivity by reducing false negatives when used together in dense breasts.
Evolving Trends in Breast MRI
Presentation on Evolving Trends in Breast MRI by Dr. Harriett B. Borofsky, Director of Breast Imaging, Mills-Peninsula Women's Center.
BCT - AIIMS Experience
The document summarizes breast conservation therapy (BCT) experience at IRCH-AIIMS in New Delhi, India. It discusses the evolution and rationale for BCT, techniques used including oncoplastic surgery, indications and contraindications. The IRCH-AIIMS protocol for BCT involves lumpectomy, axillary dissection, whole breast radiotherapy with tumor bed boost. Of 272 BCT cases, 5-year disease-free and overall survival were 76% and 92%. BCT is underutilized but offers cosmetic and psychological advantages over mastectomy for early breast cancer when adequate infrastructure and multidisciplinary care is available.
Breast cancer
Breast cancer is a common and serious form of cancer that affects millions of women globally each year. It starts in the breast tissue and can spread to other parts of the body if not detected early. Some key risk factors include gender, age, family history and lifestyle factors. Symptoms may include a breast lump, skin changes, nipple discharge or inversion. Diagnosis involves examinations, mammography, ultrasound and biopsy. Cancer is staged according to tumor size and spread. Treatment options include surgery to remove all or part of the breast, chemotherapy, radiation therapy, hormone therapy and targeted drug therapies. The goal is cure, remission or palliation depending on the stage and type of cancer.
Mammography
Mammography is the cornerstone imaging modality for breast cancer screening and diagnosis. It involves two standard views - craniocaudal and mediolateral oblique. Additional spot views may be needed based on findings. Image quality is optimized through use of specific equipment like molybdenum targets, grids, and compression to reduce thickness. Mammography finds masses and suspicious calcifications and uses the BI-RADS assessment system to characterize findings and guide need for biopsy. Regular screening can detect cancers early and improve outcomes.
25632789 01-basics1-advanced-mammo-system
This document provides an overview of mammography and the specialized equipment needed to perform it. Mammography requires high resolution and contrast to detect small breast lesions. Dedicated mammography equipment has a molybdenum target and rhodium filter to produce low-energy x-rays best suited for soft breast tissue. It also uses a small focal spot, grid, and compression to reduce noise and improve image quality while minimizing radiation dose. Stereotactic biopsy systems allow targeted needle biopsies of lesions using two x-ray angles to calculate the three-dimensional location.
Screening
This document summarizes guidelines for breast and lung cancer screening. It discusses various screening modalities including breast self-exams, clinical breast exams, mammography, breast MRI, and lung cancer screening. For breast cancer screening, it provides recommendations for average risk women, high risk women, and special populations. Screening guidelines vary depending on risk level, but in general recommend annual mammograms starting at age 40-50 and adding breast MRI for high risk women. Lung cancer screening with low-dose CT is recommended annually for certain high risk individuals.
Ijetcas14 472
This document discusses techniques for early detection of breast cancer through image processing of mammograms. It begins by introducing breast cancer and the importance of early detection. It then discusses current mammography screening approaches, including the two standard views and BI-RADS assessment system. The key abnormalities that may indicate breast cancer are described: masses with characteristics like shape, margin, density; calcifications described by size, shape and clustering; architectural distortion; and asymmetries. Current challenges are noted around detecting calcifications and masses in dense breast tissue. The paper aims to review techniques used in image processing for early breast cancer detection, including preprocessing, segmentation, and decomposition steps typically used.
Role of mammography and MRI in Breast disorders
Mammography is an x-ray test used to aid in the early detection and diagnosis of breast diseases in women. It uses low-dose radiation to produce images of the breast tissue. Screening mammograms are used to look for signs of breast cancer in women without symptoms, while diagnostic mammograms are used when abnormalities are detected or a woman has breast symptoms. Mammograms produce images of the breast tissue and can detect abnormalities such as masses, calcifications, architectural distortions, and asymmetries that may indicate breast cancer. The images are analyzed according to the Breast Imaging Reporting and Data System (BI-RADS) to determine if follow-up is needed. Digital mammography provides enhanced image quality compared to traditional film
Nico Karssemeijer
1) The document discusses the use of computer-aided detection (CAD) systems in mammography to help radiologists detect breast cancer.
2) An observer study found that radiologists' cancer detection performance improved when they interactively reviewed CAD marks compared to unaided reading.
3) Non-radiologists saw more benefit from interactive CAD than experienced radiologists. The study suggests CAD could help less experienced mammogram readers.
Breast cancer screening
Here in these slides we have explain about the Breast cancer Screening with the help of which one can get the x-ray image to identify the breast cancer and it is a mammogram which is used when one have no symptoms.
Sophie Taieb : Breast MRI indication 2014
Breast MRI has poor specificity but can provide useful information when used appropriately according to evidence-based guidelines. It has high sensitivity for detecting breast cancer but many benign lesions also enhance, leading to false positives. MRI is best used to further evaluate lesions already detected by other imaging when biopsy is not possible, to screen high-risk patients, and assess response to neoadjuvant chemotherapy or detect recurrence. Strict technical protocols and reporting standards help optimize MRI's clinical utility while minimizing unnecessary additional procedures due to false positives.
S taieb advanced breast lesion imaging jfim hanoi 2015
S taieb advanced breast lesion imaging jfim hanoi 2015JFIM - Journées Francophones d'Imagerie Médicale
This document discusses imaging techniques for assessing the size of advanced breast lesions over 5 cm. Studies have shown ultrasound generally overestimates size compared to mammography but is more accurate than physical examination alone. MRI has shown the strongest correlation to pathological tumor size, followed by tomosynthesis, mammography, and ultrasound. Assessing size accurately is important for surgical planning of large breast cancers.Original StudyType of Breast Cancer Diagnosis, Screening,a.docx
Original Study
Type of Breast Cancer Diagnosis, Screening,
and Survival
Carla Cedolini,1 Serena Bertozzi,1 Ambrogio P. Londero,2 Sergio Bernardi,3,4
Luca Seriau,1 Serena Concina,1 Federico Cattin,1 Andrea Risaliti1
Abstract
Organized, invitational breast cancer screening in our population succeeded in detecting early-stage tumors,
which have been consequently treated more frequently with breast and axillary conservative surgery, com-
plementary breast irradiation, and eventual hormonal therapy. The diagnosis of invasive cancer with screening
in our population resulted in a survival gain at 5 years from the diagnosis.
Introduction: Breast cancer screening is known to reduce mortality. In the present study, we analyzed the prevalence
of breast cancers detected through screening, before and after introduction of an organized screening, and we
evaluated the overall survival of these patients in comparison with women with an extrascreening imaging-detected
breast cancer or those with palpable breast cancers. Materials and Methods: We collected data about all women
who underwent a breast operation for cancer in our department between 2001 and 2008, focusing on type of tumor
diagnosis, tumor characteristics, therapies administered, and patient outcome in terms of overall survival, and re-
currences. Data was analyzed by R (version 2.15.2), and P < .05 was considered significant. Results: Among the 2070
cases of invasive breast cancer we considered, 157 were detected by regional mammographic screening (group A),
843 by extrascreening breast imaging (group B: 507 by mammography and 336 by ultrasound), and 1070 by extra-
screening breast objective examination (group C). The 5-year overall survival in groups A, B, and C were, respectively,
99% (95% CI, 98%-100%), 98% (95% CI, 97%-99%), and 91% (95% CI, 90%-93%), with a significant difference
between the first 2 groups and the third (P < .05) and a trend between groups A and B (P ¼ .081). Conclusion: The
diagnosis of invasive breast cancer with screening in our population resulted in a survival gain at 5 years from the
diagnosis, but a longer follow-up is necessary to confirm this data.
Clinical Breast Cancer, Vol. 14, No. 4, 235-40 ª 2014 Elsevier Inc. All rights reserved.
Keywords: Breast cancer, Breast cancer screening, Invasive breast cancer, Mammographic screening, Overall survival
Introduction
Because of the detection of early-stage tumors, breast cancer
screening reduced breast cancer mortality in Europe by 25%-31%
in patients who were invited for screening and by 38%-48% in
those who were actually screened during the last decade of the
twentieth century and the first decade of the twenty-first.1 In our
region of Italy, an organized breast cancer screening was firstly intro-
duced in 2005, but despite the high compliance of invited women
1Clinic of Surgery
2Clinic of Obstetrics and Gynecology
University of Udine, Udine, Italy
3Department of Surgery, Ospedale Civile di Latisana, Udine, Italy
4 ...
RSNA: van Colen: Breast Density
The document discusses variation in how radiologists assess breast density on mammograms. In a study of 250 mammograms read by 8 radiologists, there was significant variability, with full agreement on density in only 28% of cases. Radiologists disagreed on the distinction between scattered fibroglandular tissue and heterogeneously dense tissue in about 32% of cases. Standardizing breast density assessment is important for accurately determining cancer risk and recommending appropriate screening.
More Related Content
What's hot
Breast imaging pitffals mri p taourel
Breast MRI can have both high sensitivity and specificity for cancer detection but also poses challenges. Specificity may be around 70-90% depending on the population and comparison to mammography. Sensitivity also varies based on the gold standard used, ranging from over 95% in many studies to around 75% for screening studies. Both false positives and false negatives can occur for reasons such as artifacts, normal breast tissue, benign lesions, tumor characteristics like size, and interpretation errors. The document provides guidance on analyzing lesions, potential pitfalls, and ways to improve accuracy such as recognizing pseudo-enhancement, accounting for clinical context, and recommending appropriate follow up.
Riga 2016TomoCESMcombo
- Kettering General Hospital Breast Unit went digital between 2010-2012 and implemented tomosynthesis and contrast-enhanced spectral mammography (CESM) to improve cancer detection for women with dense breasts.
- A review of 50 patients who received tomosynthesis found it aided diagnosis in 36 patients (69%), providing extra information in 22 patients and more detailed information in 7 patients.
- A prospective study of 117 CESM exams found it to be as sensitive as MRI in detecting cancer and impacted management for 30% of cancer patients. CESM provided accurate sizing for invasive cancers but was less accurate for lobular cancers and cancers with ductal carcinoma in situ.
Rx of mammaoccult cancer
Breast Conservation in the Setting of Contemporary
Multimodality Treatment Provides Excellent Outcomes
for Patients with Occult Primary Breast Cancer
Breast Cancer not Detected on MRI
This study evaluated the sensitivity of breast MRI for detecting breast cancers. Of 222 cancers, MRI correctly identified 213 but missed 9 cancers (sensitivity of 96.8%). The 7 true false-negatives included 4 DCIS lesions and 3 invasive cancers. False-negative lesions were often small or obscured by surrounding enhancing breast tissue. While MRI is highly sensitive for breast cancer, a small percentage of cancers can be missed, particularly DCIS and cancers in a background of diffuse parenchymal enhancement.
ABC1 - N. Houssami - Overview of imaging tests for assessment of metastases i...
ABC1 - N. Houssami - Overview of imaging tests for assessment of metastases i...European School of Oncology
The document summarizes evidence from two systematic reviews on imaging tests for detecting bone metastases in breast cancer. The reviews found 16 studies comparing the accuracy of different tests, but the studies were limited by small sample sizes, selection bias, and heterogeneous reference standards of varying quality. While PET or PET/CT appeared more sensitive than bone scans in seven studies, the heterogeneity and risk of misclassification means differences in test accuracy between studies may not represent true differences and prevents pooling of the data. Overall, the evidence was insufficient to support one imaging test over others for detection of bone metastases from breast cancer.ShearWave™ Elastography in Breast Cancer Patient Management: Clinical Researc...
With 100 peer-reviewed publications, SuperSonic Imagine’s proprietary ShearWave™ Elastography (SWE™) is the most clinically studied shear-wave based elastography for breast lesion characterization.
In this all new webinar, we will walk you through a literature review that will help you to familiarize yourself with clinical research results related to the use of ShearWave™ Elastography (SWE™) within breast ultrasound imaging.
Breast screening pallavi
This document provides information on breast cancer screening and prevention. It discusses screening principles and guidelines for mammography, MRI, ultrasound and other screening techniques. It outlines high-risk factors for breast cancer and recommends annual screening starting at age 30-40 for high-risk individuals, including those with BRCA gene mutations or family history. Screening mammography every 1-2 years is recommended for average risk women starting at age 40. Chemoprevention with tamoxifen or raloxifene can lower breast cancer risk in high risk postmenopausal women. Genetic testing guidelines are also provided.
Breast screening with ultrasound in patients with mammography-negative dense ...
The document analyzes the frequency of interval cancers in dense breasts screened with mammography and ultrasound compared to non-dense breasts screened with only mammography. It finds that the frequency of interval cancers in dense breasts screened with both tests is similar to non-dense breasts screened with only mammography. This finding provides convincing evidence that ultrasound improves mammography's sensitivity by reducing false negatives when used together in dense breasts.
Evolving Trends in Breast MRI
Presentation on Evolving Trends in Breast MRI by Dr. Harriett B. Borofsky, Director of Breast Imaging, Mills-Peninsula Women's Center.
BCT - AIIMS Experience
The document summarizes breast conservation therapy (BCT) experience at IRCH-AIIMS in New Delhi, India. It discusses the evolution and rationale for BCT, techniques used including oncoplastic surgery, indications and contraindications. The IRCH-AIIMS protocol for BCT involves lumpectomy, axillary dissection, whole breast radiotherapy with tumor bed boost. Of 272 BCT cases, 5-year disease-free and overall survival were 76% and 92%. BCT is underutilized but offers cosmetic and psychological advantages over mastectomy for early breast cancer when adequate infrastructure and multidisciplinary care is available.
Breast cancer
Breast cancer is a common and serious form of cancer that affects millions of women globally each year. It starts in the breast tissue and can spread to other parts of the body if not detected early. Some key risk factors include gender, age, family history and lifestyle factors. Symptoms may include a breast lump, skin changes, nipple discharge or inversion. Diagnosis involves examinations, mammography, ultrasound and biopsy. Cancer is staged according to tumor size and spread. Treatment options include surgery to remove all or part of the breast, chemotherapy, radiation therapy, hormone therapy and targeted drug therapies. The goal is cure, remission or palliation depending on the stage and type of cancer.
Mammography
Mammography is the cornerstone imaging modality for breast cancer screening and diagnosis. It involves two standard views - craniocaudal and mediolateral oblique. Additional spot views may be needed based on findings. Image quality is optimized through use of specific equipment like molybdenum targets, grids, and compression to reduce thickness. Mammography finds masses and suspicious calcifications and uses the BI-RADS assessment system to characterize findings and guide need for biopsy. Regular screening can detect cancers early and improve outcomes.
25632789 01-basics1-advanced-mammo-system
This document provides an overview of mammography and the specialized equipment needed to perform it. Mammography requires high resolution and contrast to detect small breast lesions. Dedicated mammography equipment has a molybdenum target and rhodium filter to produce low-energy x-rays best suited for soft breast tissue. It also uses a small focal spot, grid, and compression to reduce noise and improve image quality while minimizing radiation dose. Stereotactic biopsy systems allow targeted needle biopsies of lesions using two x-ray angles to calculate the three-dimensional location.
Screening
This document summarizes guidelines for breast and lung cancer screening. It discusses various screening modalities including breast self-exams, clinical breast exams, mammography, breast MRI, and lung cancer screening. For breast cancer screening, it provides recommendations for average risk women, high risk women, and special populations. Screening guidelines vary depending on risk level, but in general recommend annual mammograms starting at age 40-50 and adding breast MRI for high risk women. Lung cancer screening with low-dose CT is recommended annually for certain high risk individuals.
Ijetcas14 472
This document discusses techniques for early detection of breast cancer through image processing of mammograms. It begins by introducing breast cancer and the importance of early detection. It then discusses current mammography screening approaches, including the two standard views and BI-RADS assessment system. The key abnormalities that may indicate breast cancer are described: masses with characteristics like shape, margin, density; calcifications described by size, shape and clustering; architectural distortion; and asymmetries. Current challenges are noted around detecting calcifications and masses in dense breast tissue. The paper aims to review techniques used in image processing for early breast cancer detection, including preprocessing, segmentation, and decomposition steps typically used.
Role of mammography and MRI in Breast disorders
Mammography is an x-ray test used to aid in the early detection and diagnosis of breast diseases in women. It uses low-dose radiation to produce images of the breast tissue. Screening mammograms are used to look for signs of breast cancer in women without symptoms, while diagnostic mammograms are used when abnormalities are detected or a woman has breast symptoms. Mammograms produce images of the breast tissue and can detect abnormalities such as masses, calcifications, architectural distortions, and asymmetries that may indicate breast cancer. The images are analyzed according to the Breast Imaging Reporting and Data System (BI-RADS) to determine if follow-up is needed. Digital mammography provides enhanced image quality compared to traditional film
Nico Karssemeijer
1) The document discusses the use of computer-aided detection (CAD) systems in mammography to help radiologists detect breast cancer.
2) An observer study found that radiologists' cancer detection performance improved when they interactively reviewed CAD marks compared to unaided reading.
3) Non-radiologists saw more benefit from interactive CAD than experienced radiologists. The study suggests CAD could help less experienced mammogram readers.
Breast cancer screening
Here in these slides we have explain about the Breast cancer Screening with the help of which one can get the x-ray image to identify the breast cancer and it is a mammogram which is used when one have no symptoms.
Sophie Taieb : Breast MRI indication 2014
Breast MRI has poor specificity but can provide useful information when used appropriately according to evidence-based guidelines. It has high sensitivity for detecting breast cancer but many benign lesions also enhance, leading to false positives. MRI is best used to further evaluate lesions already detected by other imaging when biopsy is not possible, to screen high-risk patients, and assess response to neoadjuvant chemotherapy or detect recurrence. Strict technical protocols and reporting standards help optimize MRI's clinical utility while minimizing unnecessary additional procedures due to false positives.
S taieb advanced breast lesion imaging jfim hanoi 2015
S taieb advanced breast lesion imaging jfim hanoi 2015JFIM - Journées Francophones d'Imagerie Médicale
This document discusses imaging techniques for assessing the size of advanced breast lesions over 5 cm. Studies have shown ultrasound generally overestimates size compared to mammography but is more accurate than physical examination alone. MRI has shown the strongest correlation to pathological tumor size, followed by tomosynthesis, mammography, and ultrasound. Assessing size accurately is important for surgical planning of large breast cancers.What's hot (20)
ABC1 - N. Houssami - Overview of imaging tests for assessment of metastases i...
ABC1 - N. Houssami - Overview of imaging tests for assessment of metastases i...
ShearWave™ Elastography in Breast Cancer Patient Management: Clinical Researc...
ShearWave™ Elastography in Breast Cancer Patient Management: Clinical Researc...
Breast screening with ultrasound in patients with mammography-negative dense ...
Breast screening with ultrasound in patients with mammography-negative dense ...
S taieb advanced breast lesion imaging jfim hanoi 2015
S taieb advanced breast lesion imaging jfim hanoi 2015
Similar to Sure Touch Clinical Studies
Original StudyType of Breast Cancer Diagnosis, Screening,a.docx
Original Study
Type of Breast Cancer Diagnosis, Screening,
and Survival
Carla Cedolini,1 Serena Bertozzi,1 Ambrogio P. Londero,2 Sergio Bernardi,3,4
Luca Seriau,1 Serena Concina,1 Federico Cattin,1 Andrea Risaliti1
Abstract
Organized, invitational breast cancer screening in our population succeeded in detecting early-stage tumors,
which have been consequently treated more frequently with breast and axillary conservative surgery, com-
plementary breast irradiation, and eventual hormonal therapy. The diagnosis of invasive cancer with screening
in our population resulted in a survival gain at 5 years from the diagnosis.
Introduction: Breast cancer screening is known to reduce mortality. In the present study, we analyzed the prevalence
of breast cancers detected through screening, before and after introduction of an organized screening, and we
evaluated the overall survival of these patients in comparison with women with an extrascreening imaging-detected
breast cancer or those with palpable breast cancers. Materials and Methods: We collected data about all women
who underwent a breast operation for cancer in our department between 2001 and 2008, focusing on type of tumor
diagnosis, tumor characteristics, therapies administered, and patient outcome in terms of overall survival, and re-
currences. Data was analyzed by R (version 2.15.2), and P < .05 was considered significant. Results: Among the 2070
cases of invasive breast cancer we considered, 157 were detected by regional mammographic screening (group A),
843 by extrascreening breast imaging (group B: 507 by mammography and 336 by ultrasound), and 1070 by extra-
screening breast objective examination (group C). The 5-year overall survival in groups A, B, and C were, respectively,
99% (95% CI, 98%-100%), 98% (95% CI, 97%-99%), and 91% (95% CI, 90%-93%), with a significant difference
between the first 2 groups and the third (P < .05) and a trend between groups A and B (P ¼ .081). Conclusion: The
diagnosis of invasive breast cancer with screening in our population resulted in a survival gain at 5 years from the
diagnosis, but a longer follow-up is necessary to confirm this data.
Clinical Breast Cancer, Vol. 14, No. 4, 235-40 ª 2014 Elsevier Inc. All rights reserved.
Keywords: Breast cancer, Breast cancer screening, Invasive breast cancer, Mammographic screening, Overall survival
Introduction
Because of the detection of early-stage tumors, breast cancer
screening reduced breast cancer mortality in Europe by 25%-31%
in patients who were invited for screening and by 38%-48% in
those who were actually screened during the last decade of the
twentieth century and the first decade of the twenty-first.1 In our
region of Italy, an organized breast cancer screening was firstly intro-
duced in 2005, but despite the high compliance of invited women
1Clinic of Surgery
2Clinic of Obstetrics and Gynecology
University of Udine, Udine, Italy
3Department of Surgery, Ospedale Civile di Latisana, Udine, Italy
4 ...
RSNA: van Colen: Breast Density
The document discusses variation in how radiologists assess breast density on mammograms. In a study of 250 mammograms read by 8 radiologists, there was significant variability, with full agreement on density in only 28% of cases. Radiologists disagreed on the distinction between scattered fibroglandular tissue and heterogeneously dense tissue in about 32% of cases. Standardizing breast density assessment is important for accurately determining cancer risk and recommending appropriate screening.
Van colen breast density 2
The document discusses variation in how radiologists assess breast density on mammograms. In a study of 250 mammograms read by 8 radiologists, there was significant variability, with full agreement on density in only 28% of cases. Radiologists disagreed on the distinction between scattered fibroglandular tissue and heterogeneously dense tissue in about 32% of cases. Standardizing breast density assessment is important because density affects cancer risk estimates and screening recommendations, but current methods lack consistency.
Screening in carcinoma breast
Breast cancer screening guidelines recommend biennial mammography for women aged 50-74 in well-resourced settings, as it can reduce breast cancer mortality by around 16% compared to no screening. For limited-resource settings, the guidelines conditionally recommend clinical breast examination as a low-cost alternative. Screening intervals of less than 24 months show no added benefit over longer intervals. Shared decision making around risks of false positives and overdiagnosis is important. Early diagnosis through awareness and symptom screening is prioritized where most women present at late stages due to weak health systems.
Breast Density, Breast Cancer Risk, and California Breast Density Notificatio...
Breast Density, Breast Cancer Risk, and California Breast Density Notificatio...alamocitycancercouncil
This document discusses California's new breast density notification law (SB 1538) which mandates that radiologists report breast density to patients. It provides guidance for clinicians on how to respond to patient questions and concerns arising from the new notifications. It recommends that patients with dense breasts or other risk factors continue annual screening mammograms. For high risk patients, it suggests additional screening with MRI or ultrasound. Throughout, it aims to reassure patients about their risk levels while informing them of available screening options.br ca product monogram 042015
This document discusses risk factors for breast cancer. It notes that family history of breast cancer, personal history of breast cancer, genetic alterations like mutations in BRCA1 and BRCA2 genes, early age of first menstruation, late age of first childbirth or fewer children, hormone replacement therapy, obesity after menopause, and alcohol consumption can increase a woman's risk. It also provides details on BRCA1 and BRCA2 genes which normally help repair DNA damage but mutations can increase cancer risk.
Performance Evaluation using Supervised Learning Algorithms for Breast Cancer...
The document discusses using supervised machine learning algorithms to evaluate the performance of breast cancer diagnosis. It evaluates algorithms like perceptron, cascade-forward backpropagation, and feed-forward backpropagation on a breast cancer dataset from the Wisconsin Breast Cancer Diagnosis database. The algorithms are used to develop a process for diagnosis and prediction of breast cancer that could help physicians diagnose the disease more accurately.
A Review on Data Mining Techniques for Prediction of Breast Cancer Recurrence
The most common type of cancer in women
worldwide is the Breast Cancer. Breast cancer may be
detected early using Mammograms, probably before it's
spread. Recurrent breast cancer could occur months or years
after initial treatment. The cancer could return within the
same place because the original cancer (local recurrence), or it
may spread to different areas of your body (distant
recurrence). Early stage treatment is done not only to cure
breast cancer however additionally facilitate in preventing its
repetition/recurrence. Data mining algorithms provide
assistance in predicting the early-stage breast cancer that
continually has been difficult analysis drawback. The
projected analysis can establish the most effective algorithm
that predicts the recurrence of the breast cancer and improve
the accuracy the algorithms. Large information like Clump,
Classification, Association Rules, Prediction and Neural
Networks, Decision Trees can be analyzed using data mining
applications and techniques.
Evaluation of intrauterine pathology efficacy of diagnostic hysteroscopy in h...
This study evaluated the diagnostic accuracy of hysteroscopy compared to histopathology in assessing intrauterine pathology. 280 patients undergoing hysteroscopy for abnormal ultrasound findings, abnormal uterine bleeding, infertility or recurrent pregnancy loss were included. Hysteroscopic findings of uterine cavity lesions and endometrial characteristics were compared to histopathology results. Hysteroscopy showed high sensitivity (98.9%), specificity (97.5%), and diagnostic accuracy (98.3%) for detecting benign endometrial lesions but lower values for endometrial characterization, highlighting the need for biopsy for diagnosing conditions like hyperplasia and cancer. The study concluded hysteroscopy is a reliable tool for evaluating benign intrauterine lesions when combined
Mammography
Mammography is an important tool for early detection of breast cancer. It uses low-dose x-rays of the breast to find cancers too small to be felt. For women over 50, annual mammograms are recommended by leading health groups. Mammography works best with modern equipment that takes specialized images of the compressed breast from different angles. While no test is perfect, mammograms can find 85-90% of cancers when they are still micro in size. Early detection improves survival rates significantly. Men can also develop breast cancer, though it is much rarer, occurring in about 0.22% of cancer cases among males.
Breast and cervical cancer awareness
The presentation describes various facts about breast and cervical cancer including burden of disease, survival outcomes, need for early diagnosis and screening recommendations.
Automated Cervicography Using a Machine Learning Classifier
- A clinical decision support (CDS) classifier was trained using images and expert annotations from 1473 colposcopy patients to evaluate cervical images with an AUC of 93%
- The CDS classifier was integrated into an image portal and piloted across 7 clinics in Korea to provide automated quality assurance and risk counseling on cervical images
- In the pilot of 209 patients, CDS had similar positivity rates to cytology (18-20%) and a low inadequate rate (1%), while cervicography had a high inconclusive rate (47%)
- Preliminary results found high provider utilization of CDS and potential for it to improve cervical cancer screening, but larger studies are still needed to fully validate performance
IRJET - Classifying Breast Cancer Tumour Type using Convolution Neural Netwo...
This document presents a study that uses a convolutional neural network (CNN) deep learning model to classify breast cancer tumors as benign or malignant based on ultrasonic images. The researchers trained a CNN model using a dataset of ultrasonic breast images labeled as benign or malignant. The trained model can then analyze new ultrasonic images and determine the tumor type, which could help doctors diagnose and treat breast cancer more accurately. The document provides background on breast cancer and existing diagnosis methods, describes the proposed CNN classification system, and reviews related work applying machine learning to breast cancer analysis.
Anna Kemp | Ascertaining cases of invasive breast cancer in the 45 and Up St...
This study aimed to validate methods for identifying cases of invasive breast cancer using administrative health data instead of cancer registry data. The study compared cases identified in hospital, prescription, medical services, and survey data to a cancer registry as the gold standard. The study found some individual data sources like hospital diagnoses had high predictive value and sensitivity. Combining data sources improved identification, with breast surgery plus radiotherapy or prescriptions identifying 92% of registry cases with 97% predictive value. The study concluded administrative data can accurately identify breast cancer cases for research when registry data is unavailable.
Breast cancer managment
This document provides information on diagnosing and treating breast cancer. It discusses evaluating a patient's history and performing a physical exam. Investigation may involve fine needle aspiration biopsy or core needle biopsy to obtain samples. Breast imaging with mammography, ultrasound or MRI can further evaluate abnormalities. Staging helps determine how far cancer has spread. Surgical options include breast-conserving surgery by removing the tumor with radiation, or mastectomy by removing the entire breast. The goal is to completely remove the cancer while maximizing cosmetic results.
Applying Deep Learning to Transform Breast Cancer Diagnosis
Deep convolutional neural networks can assist pathologists in breast cancer diagnosis by automatically filtering benign tissue biopsies, identifying malignant regions and labeling important cellular features like nuclei for further analysis. Automatic detection of diagnostically relevant regions-of-interest and nuclei segmentation reduces the pathologist’s workload, while ensuring that no critical region is overlooked, rendering breast cancer diagnosis more reliable, efficient and cost-effective.
Sub14297
This document compares calcification specificity in digital mammography using soft-copy display versus screen-film mammography. Breast cancer is the most common cancer in women. Digital mammography offers advantages over screen-film mammography like enhanced resolution and contrast. The study aims to compare the specificity of detecting microcalcifications, which can indicate early breast cancer, between the two imaging methods. Sixty female patients undergoing mammography were divided into groups for either screen-film or soft-copy digital mammography. Patient data and mammogram images were analyzed using statistical and imaging software to compare detection of microcalcifications between the methods.
Breast cancer screening dr.ayman jafar
Worldwide, breast cancer is the most frequently diagnosed life-threatening cancer in women and the leading cause of cancer death in women.
Focused reproductive endocrinology and infertility (2019) guideline
Focused reproductive endocrinology and infertility (2019) image library, guideline,
Hình ảnh học siêu âm trong nội tiết sinh sản và vô sinh,
AIUM 2019,
Bs Võ Tá Sơn,
Similar to Sure Touch Clinical Studies (20)
Original StudyType of Breast Cancer Diagnosis, Screening,a.docx
Original StudyType of Breast Cancer Diagnosis, Screening,a.docx
Breast Density, Breast Cancer Risk, and California Breast Density Notificatio...
Breast Density, Breast Cancer Risk, and California Breast Density Notificatio...
Performance Evaluation using Supervised Learning Algorithms for Breast Cancer...
Performance Evaluation using Supervised Learning Algorithms for Breast Cancer...
A Review on Data Mining Techniques for Prediction of Breast Cancer Recurrence
A Review on Data Mining Techniques for Prediction of Breast Cancer Recurrence
Evaluation of intrauterine pathology efficacy of diagnostic hysteroscopy in h...
Evaluation of intrauterine pathology efficacy of diagnostic hysteroscopy in h...
Automated Cervicography Using a Machine Learning Classifier
Automated Cervicography Using a Machine Learning Classifier
IRJET - Classifying Breast Cancer Tumour Type using Convolution Neural Netwo...
IRJET - Classifying Breast Cancer Tumour Type using Convolution Neural Netwo...
Anna Kemp | Ascertaining cases of invasive breast cancer in the 45 and Up St...
Anna Kemp | Ascertaining cases of invasive breast cancer in the 45 and Up St...
Applying Deep Learning to Transform Breast Cancer Diagnosis
Applying Deep Learning to Transform Breast Cancer Diagnosis
Focused reproductive endocrinology and infertility (2019) guideline
Focused reproductive endocrinology and infertility (2019) guideline
More from Chris Miller
Third Party Litigation Funding (TPLF)
This presentation was used to inform and educate hedge funds on TPLF a few years ago. The bottom fell out of most of the hedge funds that were in my pipeline so I decided not to quit my day job.
Chris millercloud
This document discusses migrating enterprises to cloud computing. It defines cloud computing as scalable IT capabilities provided as an on-demand service over the internet. There are three service models: Infrastructure as a Service (IaaS), Platform as a Service (PaaS), and Software as a Service (SaaS). There are also four deployment models: public clouds, private clouds, hybrid clouds, and community clouds. Migrating to the cloud provides benefits like lower costs, faster innovation, and elastic resources, but also raises concerns around data security, privacy, and network performance.
Developing And Executing A Program For Labeling Compliance
The document discusses developing a program for labeling compliance. It notes that labeling has become complex due to increasing regulations from various government bodies. An ideal solution would be one that adapts to regulatory changes and lowers risks of non-compliance. Key aspects of implementing a solution include user training, validation, label design, documentation, and supplier management. The document provides an overview of developing a holistic labeling compliance program.
Prisym UDI Implementation
The document provides an overview of an event focused on implementing FDA's Unique Device Identification (UDI) regulations with minimal impact. It discusses the planned timeline for UDI regulations, the benefits of implementing barcoding using GS1 standards, how labeling systems can simplify UDI compliance, and how to implement UDI with minimal impact on an organization. Presenters will provide information on UDI requirements, discuss global standards and integration, and explain how to print UDIs on labels.
Philadelphia Dropping The Gavel On Counterfeit Drugs
The document discusses issues around counterfeit drugs and strategies for addressing them through product serialization and codification. It notes the large and growing problem of counterfeit drugs, outlines regulatory pressures in Europe and the US to implement serialization, and discusses benefits serialization can provide to businesses including improved supply chain management, authentication of products, and protection of brand integrity.
Prisym Compliance
The document discusses challenges in the life sciences industry related to drug and device labeling including rising costs, global compliance, and risk of medication errors. It then introduces PRISYM Life Science software as a labeling solution that provides full compliance, security, validation support, and integration capabilities to address these challenges. Key features of PRISYM Life Science include being purpose-built for GMP compliance, secure electronic records, customization options, and use across the product development lifecycle from clinical trials to distribution.
More from Chris Miller (6)
Developing And Executing A Program For Labeling Compliance
Developing And Executing A Program For Labeling Compliance
Philadelphia Dropping The Gavel On Counterfeit Drugs
Philadelphia Dropping The Gavel On Counterfeit Drugs
Recently uploaded
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
The Best Ayurvedic Antacid Tablets in India
Treat the symptoms of indigestion, heartburn and stomach reflux with the 10 Best Ayurvedic Antacid Tablets in India.
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Learn about body grief and ways to cope with it. We will also explore methods to heal from this challenging experience.
ABDOMINAL TRAUMA in pediatrics part one.
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Adhd Medication Shortage Uk - trinexpharmacy.com
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Top-Vitamin-Supplement-Brands-in-India List
Swisschem Dermacare provides the Top 10 Vitamin Supplement Brands in India. To know more about us give us call at our official number
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
STIs may cause PID. For the both disease, herbal medicine Fuyan Pill can be a solution.
Best Ayurvedic medicine for Gas and Indigestion
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxMGM SCHOOL/COLLEGE OF NURSING
Identification and nursing management of congenital malformations Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
A Classical Text Review on Basavarajeeyam
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Recently uploaded (20)
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Sure Touch Clinical Studies
- 4. Clinical Lesion Images Shape and Hardness
- 16. Comparison of Imaging Methods
- 22. Thank you
- 23. Market Opportunity for SureTouch Second Market Opportunity Detection Diagnosis CBE Mammography Breast US MRI FNA, Core & Open Biopsy OB/GYN, Women’s Health, PPC Radiology Surgeons North America Western Europe Australia Eastern Europe Middle East China, India, Asia ROW Standard of Care Major Market Opportunity